DocuSign Shares Fall After Earnings Beat, AI Prospects in Focus

DocuSign Shares Fall After Earnings Beat, AI Prospects in Focus

NEW YORK, June 4, 2026, 18:04 (EDT)

Docusign Inc. shares dropped in late trading Thursday after the company topped Wall Street estimates for first-quarter profit and revenue but stuck close to consensus on guidance, keeping investors cautious about its AI growth story. The stock slipped 2.8% to finish at $50.94, then slid another 4.2% to $48.78 as of 5:45 p.m. EDT.

Docusign’s latest step is drawing attention as investors want to see if its e-signature service can grow into a full contract automation platform. In the run-up to earnings, the market was watching to see if the company’s focus on artificial intelligence would “accelerate growth” as the core e-signature market matures and digital signatures are now just standard. Investing.com

Nasdaq wraps up regular trading at 4 p.m. ET. After-hours goes to 8 p.m., and that’s where the move hit, with lighter volume making things more jumpy. But the message was clear: the earnings beat alone didn’t explain it.

Docusign reported revenue of $830.2 million, a gain of 9% from last year, with adjusted earnings coming in at $1.09 per share. That topped analyst estimates for $1.00 a share and revenue of $823.23 million, Investing.com said. The company’s non-GAAP results leave out items like stock-based pay and acquisition amortization, which Docusign says better represents core operations.

DocuSign gave a second-quarter revenue outlook of $865 million to $869 million, landing the midpoint around the $866 million analyst consensus. Its fiscal 2027 guidance was $3.49 billion to $3.502 billion, again with the midpoint barely above consensus at $3.49 billion. The muted numbers didn’t do much for traders looking for a bolder AI story from the company.

Docusign said its Intelligent Agreement Management platform — IAM, the company’s AI contract software — made up 12.6% of total annual recurring revenue, up from 10.8% three months ago. ARR, or annual recurring revenue, tracks the annualized contract value. CEO Allan Thygesen called out “continued growing demand” for IAM in the quarter and pointed to “durable revenue growth, substantial free cash flow, and record share buybacks.” PR Newswire

Chief Financial Officer Blake Grayson said in prepared remarks that “growth remains resilient as we evolve into an AI-first platform.” Grayson also said IAM bookings saw their fastest year-over-year growth in North American enterprise, faster than any other segment. He said IAM is still on track to make up about 18% of total ARR by fiscal year-end. Q4 Capital

Stronger cash generation helped Docusign in the quarter. Free cash flow jumped to $289.4 million from $227.8 million a year ago. The company bought back $317.5 million of its stock, up from $183.4 million in the same period last year. Docusign closed the quarter with $1.0 billion in cash, cash equivalents and investments.

Competition is tough. Buyers looking at Docusign eSignature also check out Adobe’s Acrobat Sign, PandaDoc and Dropbox Sign, according to Gartner Peer Insights. That’s part of why Docusign wants people to talk about more than digital signatures and start thinking about AI-powered contract workflows.

Docusign talked up customer stories in its prepared remarks. Jim Fick, managing director of global ops at Experian, said IAM “simplify and connect” quote-to-cash apps. HSBC’s chief AI officer David Rice said the bank used Docusign IAM to “digitize and simplify” credit lending. Q4 Capital

The shares moved while the broader U.S. market was mixed. The S&P 500 gained 0.41% and the Dow ended at a record high. The Nasdaq Composite lost 0.09% after chip stocks dragged on tech shares.

Docusign is warning that AI may take longer to lift growth than investors hope. The company pointed to risks from rivals, the economy, renewals, and building and selling new IAM and AI tools. Its outlook is almost right on consensus, so the market might not be patient if AI adoption drags.

Docusign is pointing to its base of 40,000 IAM customers as the next lever for ARR growth, but is only guiding to 8.25% to 8.75% ARR growth for fiscal 2027. The stock is not responding to the latest clean earnings beat, showing investors want to see more.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Merck Stock Gains as Keytruda Concerns Ease, Investors Look to Pipeline Bets
Previous Story

Merck Stock Gains as Keytruda Concerns Ease, Investors Look to Pipeline Bets

Fidelity Just Made SpaceX IPO Access Easier. The Catch Is Getting Shares
Next Story

Fidelity Just Made SpaceX IPO Access Easier. The Catch Is Getting Shares